Neuland Laboratories Board Meeting for Q1 FY27 Results

Key Dates

• Board Meeting Date: Wednesday, August 5, 2026
• Quarter Ended: June 30, 2026 (Q1 FY27)
• Trading Window Closure Period: From July 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026
• Disclosure Date: July 20, 2026

Purpose of Board Meeting

The Board of Directors will meet to approve and take on record the unaudited financial results of the Company for the quarter ended June 30, 2026, covering both Standalone and Consolidated financial statements.

Entities Involved

• Issuer: Neuland Laboratories Limited
• Regulatory Recipients: BSE Limited and National Stock Exchange of India Ltd